Literature DB >> 23197807

The effect of extended first passage culture on the proliferation and differentiation of human marrow-derived mesenchymal stem cells.

Donald P Lennon1, Mark D Schluchter, Arnold I Caplan.   

Abstract

Human marrow-derived mesenchymal stem cells (hMSCs) have been investigated for more than 20 years. They have been shown to be therapeutic in a number of animal models and are currently in use in more than 200 clinical trials, thus documenting their importance in the field of translational medicine. Standard protocols for the passage and collection of hMSCs involve trypsinization of preconfluent cultures. This practice is based, at least in part, on concerns that the multipotency of these cells would be diminished if the cultures became confluent. To test this concern, hMSCs were isolated and maintained in standard culture conditions in primary culture and were then subcultured after 2 weeks. The resulting first passage cultures were divided into two groups: those that were subcultured at the normal frequency, usually at 7 days for each passage (referred to as standard conditions [SC]), and those that were maintained for up to 53 days without being further subcultured (extended first passage [EFP]). At the end of the second passage and each of five subsequent subcultures for cells in SC (i.e., through passage 7), complementary EFP cultures were also trypsinized. Cells from each group were counted, resuspended in serum-free medium, and assayed to determine the ability of the cells to differentiate along osteogenic, chondrogenic, and adipogenic lineages. Cells in SC experienced an average of 27 population doublings through seven passages, whereas hMSCs in EFP achieved approximately 16 population doublings after 34 days but demonstrated very little increase in cell number after that time. The ability of hMSCs in EFP to produce bone in ceramic cubes implanted subcutaneously in immunocompromised mice and to differentiate into cartilage in pellet or aggregate culture was at least equivalent to that of the cells in SC through seven passages, whereas the capacity of the EFP hMSCs to produce lipid droplets in adipogenic conditions was maintained but was diminished relative to that of SC cells.

Entities:  

Mesh:

Year:  2012        PMID: 23197807      PMCID: PMC3659698          DOI: 10.5966/sctm.2011-0011

Source DB:  PubMed          Journal:  Stem Cells Transl Med        ISSN: 2157-6564            Impact factor:   6.940


  25 in total

1.  Proliferation kinetics and differentiation potential of ex vivo expanded human bone marrow stromal cells: Implications for their use in cell therapy.

Authors:  A Banfi; A Muraglia; B Dozin; M Mastrogiacomo; R Cancedda; R Quarto
Journal:  Exp Hematol       Date:  2000-06       Impact factor: 3.084

2.  Characterizing medullary and human mesenchymal stem cell-derived adipocytes.

Authors:  Danielle L Mackay; Paul J Tesar; Li-Nuo Liang; Stephen E Haynesworth
Journal:  J Cell Physiol       Date:  2006-06       Impact factor: 6.384

Review 3.  Marrow stromal cells as stem cells for nonhematopoietic tissues.

Authors:  D J Prockop
Journal:  Science       Date:  1997-04-04       Impact factor: 47.728

4.  Cultivation of rat marrow-derived mesenchymal stem cells in reduced oxygen tension: effects on in vitro and in vivo osteochondrogenesis.

Authors:  D P Lennon; J M Edmison; A I Caplan
Journal:  J Cell Physiol       Date:  2001-06       Impact factor: 6.384

5.  In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells.

Authors:  B Johnstone; T M Hering; A I Caplan; V M Goldberg; J U Yoo
Journal:  Exp Cell Res       Date:  1998-01-10       Impact factor: 3.905

6.  Multilineage potential of adult human mesenchymal stem cells.

Authors:  M F Pittenger; A M Mackay; S C Beck; R K Jaiswal; R Douglas; J D Mosca; M A Moorman; D W Simonetti; S Craig; D R Marshak
Journal:  Science       Date:  1999-04-02       Impact factor: 47.728

7.  FGF-2 enhances the mitotic and chondrogenic potentials of human adult bone marrow-derived mesenchymal stem cells.

Authors:  Luis A Solchaga; Kitsie Penick; John D Porter; Victor M Goldberg; Arnold I Caplan; Jean F Welter
Journal:  J Cell Physiol       Date:  2005-05       Impact factor: 6.384

8.  Mesenchymal stem cells from the outer ear: a novel adult stem cell model system for the study of adipogenesis.

Authors:  Jong-Seop Rim; Randall L Mynatt; Barbara Gawronska-Kozak
Journal:  FASEB J       Date:  2005-04-27       Impact factor: 5.191

9.  The chondrogenic potential of human bone-marrow-derived mesenchymal progenitor cells.

Authors:  J U Yoo; T S Barthel; K Nishimura; L Solchaga; A I Caplan; V M Goldberg; B Johnstone
Journal:  J Bone Joint Surg Am       Date:  1998-12       Impact factor: 5.284

10.  Fibroblast growth factor-2 enhances proliferation and delays loss of chondrogenic potential in human adult bone-marrow-derived mesenchymal stem cells.

Authors:  Luis A Solchaga; Kitsie Penick; Victor M Goldberg; Arnold I Caplan; Jean F Welter
Journal:  Tissue Eng Part A       Date:  2010-03       Impact factor: 3.845

View more
  14 in total

1.  A reproducible immunopotency assay to measure mesenchymal stromal cell-mediated T-cell suppression.

Authors:  Debra D Bloom; John M Centanni; Neehar Bhatia; Carol A Emler; Diana Drier; Glen E Leverson; David H McKenna; Adrian P Gee; Robert Lindblad; Derek J Hei; Peiman Hematti
Journal:  Cytotherapy       Date:  2014-11-21       Impact factor: 5.414

2.  Defining recovery neurobiology of injured spinal cord by synthetic matrix-assisted hMSC implantation.

Authors:  Alexander E Ropper; Devang K Thakor; InBo Han; Dou Yu; Xiang Zeng; Jamie E Anderson; Zaid Aljuboori; Soo-Woo Kim; Hongjun Wang; Richard L Sidman; Ross D Zafonte; Yang D Teng
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-17       Impact factor: 11.205

Review 3.  Local and targeted drug delivery for bone regeneration.

Authors:  Maureen R Newman; Danielle Sw Benoit
Journal:  Curr Opin Biotechnol       Date:  2016-04-08       Impact factor: 9.740

4.  Transcriptome dynamics of long noncoding RNAs and transcription factors demarcate human neonatal, adult, and human mesenchymal stem cell-derived engineered cartilage.

Authors:  Daniel J Vail; Rodrigo A Somoza; Arnold I Caplan; Ahmad M Khalil
Journal:  J Tissue Eng Regen Med       Date:  2019-12-18       Impact factor: 3.963

5.  Human and Rat Bone Marrow-Derived Mesenchymal Stem Cells Differ in Their Response to Fibroblast Growth Factor and Platelet-Derived Growth Factor.

Authors:  Donald Lennon; Luis A Solchaga; Rodrigo A Somoza; Mark D Schluchter; Seunghee Margevicius; Arnold I Caplan
Journal:  Tissue Eng Part A       Date:  2018-08-22       Impact factor: 3.845

6.  The Habitat Assay, a Platform to Study In Vivo Properties of Human Mesenchymal Stem Cells.

Authors:  Donald P Lennon; Rodrigo A Somoza; Mark A Schluchter; Arnold I Caplan
Journal:  Tissue Eng Part A       Date:  2020-11-26       Impact factor: 3.845

7.  MicroRNA Regulation of Bone Marrow Mesenchymal Stem Cell Chondrogenesis: Toward Articular Cartilage.

Authors:  Daniel J Vail; Rodrigo A Somoza; Arnold I Caplan
Journal:  Tissue Eng Part A       Date:  2021-10-25       Impact factor: 3.845

8.  Characteristics of Pooled Wharton's Jelly Mesenchymal Stromal Cells (WJ-MSCs) and their Potential Role in Rheumatoid Arthritis Treatment.

Authors:  Suresh Kannan; Pachaiyappan Viswanathan; Pawan Kumar Gupta; Uday Kumar Kolkundkar
Journal:  Stem Cell Rev Rep       Date:  2022-02-03       Impact factor: 5.739

9.  Differentiation of bone marrow mesenchymal stem cells into chondrocytes after short term culture in alkaline medium.

Authors:  Farshad Homayouni Moghadam; Tahereh Tayebi; Maryam Dehghan; Gilda Eslami; Hamid Nadri; Alireza Moradi; Hassanali Vahedian-Ardakani; Kazem Barzegar
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2014-10-01

10.  Reductions in behavioral deficits and neuropathology in the R6/2 mouse model of Huntington's disease following transplantation of bone-marrow-derived mesenchymal stem cells is dependent on passage number.

Authors:  Julien Rossignol; Kyle D Fink; Andrew T Crane; Kendra K Davis; Matthew C Bombard; Steven Clerc; Angela M Bavar; Steven A Lowrance; Cheng Song; Steven Witte; Laurent Lescaudron; Gary L Dunbar
Journal:  Stem Cell Res Ther       Date:  2015-02-19       Impact factor: 6.832

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.